Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Introduction to a Novel Chromatin Immunoprecipitation (ChIP) Method
Friday, September 05, 2014
An informative 8-page brochure from Porvair introduces Chromatrap® ChIP assay technology.

GE Healthcare Life Sciences Launches illustra™ Single Cell GenomiPhi
Tuesday, September 02, 2014
Delivering high quality gDNA from a single cell.

Easy-to-use, Quantitative Gamma-H2AX Assay
Tuesday, September 02, 2014
Gamma H2AX pharmacodynamic assay kit for the study of double strand DNA breaks.

Versatile Range of Horizontal Gel Electrophoresis Units
Tuesday, September 02, 2014
Cleaver MultiSUB™ gel electrophoresis range for low- and high-throughput DNA and RNA applications.

Source BioScience Launches Intelligent GenomeCUBE Search Engine
Monday, September 01, 2014
Search and buying tool offers instant, simple access to millions of clone, antibody and protein products.

Onxeo Strengthens Beleodaq® Patent Protection in the U.S. Until 2027
Friday, August 29, 2014
U.S. Patent will be granted on September 16th 2014.

Lightweight Electronic Pipette Offers Enhanced Ease of Use
Thursday, August 28, 2014
Jump from minimum to maximum volume within a second.

Swift Analytical to Exhibit the DeNovix DS-11 during the ELRIG Drug Discovery 2014 Meeting
Thursday, August 28, 2014
Swift Analytical will be exhibiting the ground breaking DeNovix DS-11 microvolume spectrophotometer during the ELRIG Drug Discovery Meeting in the Innovation Zone, booth number IZ16.

GeneFiX™ DNA Saliva Collection and Purification Products
Wednesday, August 27, 2014
Isohelix is pleased to announce the launch of the new range, covering all downstream process aplications.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 2528
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv